00-4520. Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2000: Allocations for Metered-Dose Inhalers and the Space Shuttle and Titan Rockets
-
Start Preamble
AGENCY:
Environmental Protection Agency (EPA).
ACTION:
Extension of comment period for interim final rule.
SUMMARY:
The United States Environmental Protection Agency (EPA) is extending the comment period for the interim final rule published January 6, 2000 (65 FR 716). This interim final rule allocated essential use allowances for ozone depleting substances for calendar year 2000 and was effective on the date of publication. EPA published the allocation as an interim final rule and provided a 30 day comment period because the allocated quantities were lower than those contained in the proposed rule. However, companies who applied for essential use allowances as a part of the International Pharmaceutical Aerosol Consortium (IPAC) were not informed as to the amount of individual allowances they would receive for calendar year 2000 until January 25, 2000, after FDA provided these confidential numbers to EPA. EPA received comment from one of the IPAC companies stating that the original 30 day comment period would not allow sufficient time to formulate comments in response to the allocation of essential use allowances. Therefore, EPA is extending the deadline for submitting written comment on the allocation of essential-use allowances for calendar year 2000 for ozone depleting substances for use in medical devices and for use in the Space Shuttle Rockets and Titan Rockets until March 27, 2000.
DATES:
The comment period for this interim final rule is extended until March 27, 2000.
ADDRESSES:
Comments on the interim final rulemaking allocating essential use allowances for metered dose inhalers and the space shuttle and Titan Rockets (65 FR 716) should be submitted in duplicate (two copies) to: Air Docket No. A-92-13, U.S. Environmental Protection Agency, 401 M Street, SW, Room M-1500, Washington, DC, 20460. Those wishing to notify EPA of their intent to submit adverse comments on this action should contact Erin Birgfeld, U.S. Environmental Protection Agency, Stratospheric Protection Division, Office of Air and Radiation (6205J), Ariel Rios Building, 1200 Pennsylvania Avenue, NW., Washington, DC, 20460; birgfeld.erin@epa.gov; (202) 564-9079 phone and (202) 565-2095 fax.
Materials relevant to this rulemaking are contained in Docket No. A-92-13. The Docket is located in room M-1500, First Floor, Waterside Mall at the address above. The materials may be inspected from 8 a.m. until 4 p.m. Monday through Friday. A reasonable fee may be charged by EPA for copying docket materials.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Erin Birgfeld, U.S. Environmental Protection Agency, Stratospheric Protection Division, Office of Air and Radiation (6205J), Ariel Rios Building, 1200 Pennsylvania Avenue, NW., Washington, DC, 20460; birgfeld.erin@epa.gov; (202) 564-9079 phone and (202) 565-2096 fax.
Start SignatureDated: February 17, 2000.
Robert Perciasepe,
Assistant Administrator, Office of Air and Radiation.
[FR Doc. 00-4520 Filed 2-24-00; 8:45 am]
BILLING CODE 6560-50-P
Document Information
- Published:
- 02/25/2000
- Department:
- Environmental Protection Agency
- Entry Type:
- Rule
- Action:
- Extension of comment period for interim final rule.
- Document Number:
- 00-4520
- Dates:
- The comment period for this interim final rule is extended until March 27, 2000.
- Pages:
- 10025-10025 (1 pages)
- Docket Numbers:
- FRL-6542-6
- RINs:
- 2060-A173
- PDF File:
- 00-4520.pdf
- Supporting Documents:
- » International Pharmaceutical Aerosol Consortium (IPAC), Washington, DC. Request for Nomination of the MDI as an Essential Use. [A-93-39-II-A-4]
- » J.H. McCord, Jr., Lab Manager, Davis & Floyd, Incorporated [A-93-39-XI-H-2]
- » Letter from Terence Young, Western Farmers Electric Cooperative (WFEC), Anadarko, OK. [A-93-39-XI-H-7]
- » Daniel M. Panek, Director, JLI Environmental Laboratories, Auburn, NY. [A-93-39-XI-H-9]
- » Data Table: Annex I - Essential Use Nominations For 2002-2004 Authorized by the Thirteenth Meeting of the Parties (in metric tonnes). [A-93-39-XII-A-3]
- » Letter from E. Allera and T. Halpern of Buchanan Ingersoll to S. Monroe of EPA re: Imminent Change in name of Sidmak Laboratories [A-93-39-XII-A-6]
- » Nomination request for essential uses of halons - 1993 [A-93-39-I-1]
- » J. E. Henney, M.D., Commissioner, Department of Health & Human Services, Food & Drug Administration, requesting supplemental of their letter on 01-21-00 [A-93-39-VII-H-5]
- » C. Dabruzzi, National Account Manager, 3M Pharmaceuticals/ 3MDrug Delivery Systems, Minnesota Mining & Manufacturing Company (3M) [A-93-39-IX-A-8]
- » Minutes of the Meeting with the Food & Drug Administration, Environmental Protection Agency, & 3M Pharmaceuticals on 03-02-00 [A-93-39-VII-E-1]
- CFR: (1)
- 40 CFR 82